Barclays analyst Emily Field lowered the firm’s price target on Bayer to EUR 30 from EUR 40 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BAYRY:
- Bayer, AskBio announce first patient randomized in Phase II gene therapy trial
- Corteva upgraded to Buy at Loop Capital on ‘compelling’ growth drivers
- Opening Day: Gilead-backed Kyverna overshoots raised IPO expectations
- Bayer price target lowered to EUR 34 from EUR 45 at Deutsche Bank
- Trinity Biotech enters into letter of intent with Bayer for partnership
